Chandler JM - Search Results

1

Characteristics of Parkinson's Disease in Patients with and without Cognitive Impairment.

Chandler JM, Nair R, Biglan K, Ferries EA, Munsie LM, Changamire T, Patel N. Chandler JM, et al. J Parkinsons Dis. 2021;11(3):1381-1392. doi: 10.3233/JPD-202190. J Parkinsons Dis. 2021. PMID: 33720850 Free PMC article.

2

Epidemiology and economic burden of Lewy body dementia in the United States.

Desai U, Chandler J, Kirson N, Georgieva M, Cheung HC, Westermeyer B, Lane H, Biglan K. Desai U, et al. Curr Med Res Opin. 2022 Jul;38(7):1177-1188. doi: 10.1080/03007995.2022.2059978. Epub 2022 Apr 20. Curr Med Res Opin. 2022. PMID: 35442134

3

Demonstration of Clinical Meaningfulness of the Integrated Alzheimer's Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes.

Wessels AM, Belger M, Johnston JA, Yu Y, Rentz DM, Dowsett SA, Chandler J. Wessels AM, et al. J Alzheimers Dis. 2022;88(2):577-588. doi: 10.3233/JAD-220303. J Alzheimers Dis. 2022. PMID: 35694928 Free PMC article.

4

Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database.

Chandler J, Georgieva M, Desai U, Kirson N, Lane H, Cheung HC, Westermeyer B, Biglan K. Chandler J, et al. Neurol Ther. 2023 Feb;12(1):177-195. doi: 10.1007/s40120-022-00417-w. Epub 2022 Nov 15. Neurol Ther. 2023. PMID: 36378462 Free PMC article.

5

The Measurement of Everyday Cognition (ECog): Revisions and Updates.

Farias ST, Weakley A, Harvey D, Chandler J, Huss O, Mungas D. Farias ST, et al. Alzheimer Dis Assoc Disord. 2021 Jul-Sep 01;35(3):258-264. doi: 10.1097/WAD.0000000000000450. Alzheimer Dis Assoc Disord. 2021. PMID: 33901047 Free PMC article.

6

Clinical and Economic Assessment in Early-Stage Dementia by Severity and Amyloid-β Status: A 5-Year Retrospective Claims Study of GERAS-US Patients.

Chandler J, Kubisiak J. Chandler J, et al. J Alzheimers Dis. 2023;91(2):753-765. doi: 10.3233/JAD-220415. J Alzheimers Dis. 2023. PMID: 36502319 Free PMC article.

7

Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.

Chandler JM, Ye W, Mi X, Doty EG, Johnston JA. Chandler JM, et al. J Alzheimers Dis. 2024;100(2):563-578. doi: 10.3233/JAD-231166. J Alzheimers Dis. 2024. PMID: 38875031 Free PMC article.

8

Understanding the impact of slowing disease progression for individuals with biomarker-confirmed early symptomatic Alzheimer's disease.

Desai U, Gomes DA, Chandler J, Ye W, Daly M, Kirson N, Dennehy EB. Desai U, et al. Curr Med Res Opin. 2024 Oct;40(10):1719-1725. doi: 10.1080/03007995.2024.2394602. Epub 2024 Sep 1. Curr Med Res Opin. 2024. PMID: 39175422 Review.

9

Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools?

Snyder PJ, Kahle-Wrobleski K, Brannan S, Miller DS, Schindler RJ, DeSanti S, Ryan JM, Morrison G, Grundman M, Chandler J, Caselli RJ, Isaac M, Bain L, Carrillo MC. Snyder PJ, et al. Among authors: chandler j. Alzheimers Dement. 2014 Nov;10(6):853-60. doi: 10.1016/j.jalz.2014.07.158. Epub 2014 Nov 15. Alzheimers Dement. 2014. PMID: 25458309 Review.

10

Disease progression and costs at the 3-year follow-up of the GERAS-US study.

Chandler JM, Rentz DM, Zagar A, Kim Y, Schwartz RL, Fillit H. Chandler JM, et al. Alzheimers Dement (Amst). 2023 Apr 19;15(2):e12430. doi: 10.1002/dad2.12430. eCollection 2023 Apr-Jun. Alzheimers Dement (Amst). 2023. PMID: 37091310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters